Atticus Pharma

Atticus Pharma Initiates a First-in-Human Trial for Androgenic Alopecia Treatment ATC-002

April 28, 2025 /

Atticus Pharma, a clinical-stage biopharmaceutical company specializing in immunodermatology treatments, has announced the initiation of its first human clinical trial of ATC-002 for androgenic alopecia. What is Atticus Pharma? Atticus Pharma was founded in 2024 to develop pharmaceutical applications of its proprietary Z-pod® technology, a sustained-release drug delivery platform designed to improve treatment outcomes in…

Read More

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.